the SmallCapReview mailing list.
Myriad Genetics: A
personalized medicine company, that focuses on the
development and marketing of predictive, personalized, and
prognostic medicine tests worldwide.
MYGN has a collaboration with AstraZeneca for the
development of an indication for BRACAnalysis CDx. More.
SciClone Pharmaceuticals: A
revenue-generating, specialty pharmaceutical company
with a substantial commercial business in China and a product portfolio
spanning major therapeutic markets including oncology, infectious diseases
and cardiovascular disorders. More.
Intercept Pharmaceuticals: A biopharmaceutical company focused on the development and
commercialization of novel therapeutics to treat orphan and more prevalent
liver diseases utilizing its expertise in bile acid chemistry. OCA has received orphan drug
designation in both the United States and Europe for the treatment of PBC. More.
Where Small Cap Stocks Thrive Since
High Yield Small Cap Dividend Stocks For 2017...
BRACAnalysis CDx® Test Successfully Identified Metastatic Breast Cancer
Patients with Improved Outcomes from AstraZeneca's...
Prolaris® Test Significantly Improves the Risk Classification for One Third of
Men Diagnosed with Localized Prostate Cancer...
MYGN Joins Small Cap 600...
Most Wonderful Year For Small Caps...
Next Leg Of The Small Cap Rally Starts Now...
Small Caps Remain Some Of The Top Stocks To Invest In...
Cap Stocks Hit Record High...
Long And Short Of Small Cap Options...
Markets Reach New Highs...
In small-caps, the Russell 2000 Index closed at 1378.53 for a gain of 19.79
points or 1.46%.
Stocks - There's A Lot To Like About Them...
Cap Stocks - Time For Active Investing...
Reasons To Keep Small Caps...
Say Go Long Small Caps In February...
Small Cap Picks...
has the deepest diagnostic pipeline across the disease spectrum."
on MYGN here...
Raised It's EPS Guidance"
on SCLN here...
Biopharmaceutical Company Focused On The Development And Commercialization Of
Novel Therapeutics To Treat Chronic Liver Diseases."
on ICPT here...
Subscribers to our Free newsletter will receive stock reports and news alerts for small-cap stocks
via email. You can sign-up
"A Primer In Microcap
is a leading destination for small-cap picks and news. The Purpose of
SmallCapReview.com is to profile and bring awareness to companies with a market cap of
less than $1 billion, these small-cap stocks will primarily trade on the Nasdaq Small-Cap market. We also issue daily small cap
stocks to watch via various newswires. We will strive to bring you the
undiscovered, the undervalued, and the oversold. SmallCapReview.com
does not give "buy" recommendations, price targets nor
suggest entry and exit points.
"A Look at Small Cap Stocks that may no longer be Small Caps"